FLAK
发表于 2025-3-21 17:59:02
书目名称Management of Chemotherapy-Induced Nausea and Vomiting影响因子(影响力)<br> http://figure.impactfactor.cn/if/?ISSN=BK0622459<br><br> <br><br>书目名称Management of Chemotherapy-Induced Nausea and Vomiting影响因子(影响力)学科排名<br> http://figure.impactfactor.cn/ifr/?ISSN=BK0622459<br><br> <br><br>书目名称Management of Chemotherapy-Induced Nausea and Vomiting网络公开度<br> http://figure.impactfactor.cn/at/?ISSN=BK0622459<br><br> <br><br>书目名称Management of Chemotherapy-Induced Nausea and Vomiting网络公开度学科排名<br> http://figure.impactfactor.cn/atr/?ISSN=BK0622459<br><br> <br><br>书目名称Management of Chemotherapy-Induced Nausea and Vomiting被引频次<br> http://figure.impactfactor.cn/tc/?ISSN=BK0622459<br><br> <br><br>书目名称Management of Chemotherapy-Induced Nausea and Vomiting被引频次学科排名<br> http://figure.impactfactor.cn/tcr/?ISSN=BK0622459<br><br> <br><br>书目名称Management of Chemotherapy-Induced Nausea and Vomiting年度引用<br> http://figure.impactfactor.cn/ii/?ISSN=BK0622459<br><br> <br><br>书目名称Management of Chemotherapy-Induced Nausea and Vomiting年度引用学科排名<br> http://figure.impactfactor.cn/iir/?ISSN=BK0622459<br><br> <br><br>书目名称Management of Chemotherapy-Induced Nausea and Vomiting读者反馈<br> http://figure.impactfactor.cn/5y/?ISSN=BK0622459<br><br> <br><br>书目名称Management of Chemotherapy-Induced Nausea and Vomiting读者反馈学科排名<br> http://figure.impactfactor.cn/5yr/?ISSN=BK0622459<br><br> <br><br>
祖先
发表于 2025-3-21 20:50:11
http://image.papertrans.cn/m/image/622459.jpg
companion
发表于 2025-3-22 01:49:06
Clinical Management of CINV,Antiemetic guidelines have been published by NCCN , ASCO , and MASCC . These guidelines form the basis for the recommendations for the management of CINV. As new information and new studies emerge, the guidelines will evolve to provide the highest quality evidence-based clinical practice.
Pudendal-Nerve
发表于 2025-3-22 07:29:54
http://reply.papertrans.cn/63/6225/622459/622459_4.png
建筑师
发表于 2025-3-22 12:13:48
http://reply.papertrans.cn/63/6225/622459/622459_5.png
eczema
发表于 2025-3-22 13:02:07
Conclusions,milar efficacy in the prevention of acute CINV for patients receiving moderately emetogenic chemotherapy (MEC) and highly emetogenic chemotherapy (HEC). These agents do not appear to have significant efficacy in the prevention of delayed CINV, and these agents compete primarily on an economic basis.
Opponent
发表于 2025-3-22 17:46:08
http://reply.papertrans.cn/63/6225/622459/622459_7.png
filial
发表于 2025-3-22 22:31:30
http://reply.papertrans.cn/63/6225/622459/622459_8.png
adduction
发表于 2025-3-23 03:02:39
http://reply.papertrans.cn/63/6225/622459/622459_9.png
modifier
发表于 2025-3-23 08:53:08
http://reply.papertrans.cn/63/6225/622459/622459_10.png